CPHI vs GPC · rev $4.1M vs P/E 21, rev $23.49B
China Pharma Holdings Inc (CPHI) versus Genuine Parts Co (GPC) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Genuine Parts Co (GPC) is a auto parts company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported GPC revenue for 2024-12-31 was $23.49B. Net income was $904.1M. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
CPHI currently screens at market cap $29.0M. GPC currently screens at market cap $17.60B and trailing P/E 20.7.
Not investment advice. Open the CPHI and GPC stock pages for the full models.
Not investment advice.